[Comment] Another step towards defeating meningitis

Since the introduction of the MenA conjugate vaccine in the African meningitis belt through mass vaccination campaigns and its inclusion in the Essential Program on Immunization (EPI), cases of serogroup A meningococcal meningitis have disappeared. This success has provided hope of eliminating serogroup A meningococcal disease and certainly epidemics in the African meningitis belt. The novel MenACWYX conjugate vaccine (NmCV-5), which contains four additional polysaccharides, is now expected to do the same for the remaining epidemic-causing serogroups in the region.